

























































































Goodwill,! purchase! price! allocation,! real! value! creation,! value! destruction,! illusion,!









Synergies!or! rather! the!nonMachievement!of!synergies!has!been! the!major! reason! for!
many! failures!with! regard! to!mergers!and!acquisitions.!Though!success!does!exist! in!
certain! sectors.! This! brings! me! to! the! research! question! of! this! thesis:! Synergies)
achieved) in) the) Pharmaceutical) and) Beauty–Personal) Care) sectors:! Illusion) or) Real)
Value)Creation?)!
!
The! principal! purpose! of! this! research! study! is! to! carry! out! a! sectoral! comparative!
analysis,!especially!for!the!Pharmaceutical!and!Beauty–Personal!Care!sectors!as!these!
two!are!very!active!in!the!M&A!sector.!In!order!to!realize!this!analysis!and!answer!the!
core! question! of! this! paper,! three! specific! questions! have! been! answered! and! two!
hypotheses!tested!empirically.!The!first!question!deals!with!the!identification!of!common!




from! the! first! levels! of! the! synergy! map! and/or! the! fourth! and! fifth! ones.! The! first!
assumption!tested!can!be!formulated!as!follows:!There)is)no)relationship)between)the)
value) of) goodwill) and) the) purchase) price.! The! second! is:! There) is) no) relationship)





topic! of! mergers! and! acquisitions,! the! consolidated! annual/financial! reports! of! the!
acquiring!companies!from!both!sectors!including!the!2018!M&As!and!2016!IFRS!course!
slides.!The!use!of!these!secondary!data!permitted!to!collect!and!evaluate!the!essential!
primary! data.! The! automatic! function! on! econometric! software! Stata,! through! the!
commands! “regress! Goodwill! Consideration! /! DealValue”! and! “regress! Added_CFO!
GW4!Others4! Location_n”,! were! then! used! for! both,! simple! and!multiple,! regression!









higher! the!goodwill!value.!Finally,! the!multiple! regression!analysis!does!not!associate!
any!relationship!between!the!added!CFO!and!goodwill!when!measured!postMacquisition.!
It! can! be! assumed! that! no! positive! association! between!GW! and! added! CFO! is! an!
information!per)se.!In!other!words,!corporations!cannot!prove!that!the!higher!the!price,!
the!higher!the!GW,!the!higher!the!expectation!of!added!CFO.!This!may!relate!to!these!
additional! CFO! coming! from! other! decisions! such! as! restructuring! plans.! The!


































































































































































products/services,! by! expanding! into! new! territories! and! enlarging! the! existing!
products/services! categories! as! they! have! not! yet! reached! their! maturity! stage.! The!


























Indeed,! M&As! come! in! waves! and! peaks! of! heavy! M&A! activity! especially! before!
economic! crisis,! followed! by! calm! periods! of! activity! are! observed.! Six! distinct!M&A!
waves!have!been!determined!over!the!1895!–!2007!period!(Martynova!and!Renneboog,!
2005)! and! each! has! its! own! characteristics! and! explanations,! such! as! economic!




began! at! the! end! of! the! nineteenth! century! known! as! the! “Great!Merger!Wave”p! the!
second!began!at!the!end!of!World!War!Ip!the!third!wave!began!after!the!Great!Depression!
and!the!World!War!II!that!being!in!the!midM1950s!characterized!as!the!move!of!horizontal!











The! subject! of! M&As,! especially! business! combinations! in! corporate! finance! is! still!























weak! postMacquisition! integration! process! (as! executives! tend! to! think! that! after!
completing!the!deal!the!work!is!done!whereas!the!work!has!just!started),!and!a!flawed!
valuation! due! to! the! wrong! assumptions/estimations! in! the! target! company! value!
assessment2.!M&As!activity! is!effectively!not!as!simple!as! it!seems,!but! rather!a!very!
long! journey! with! many! difficulties/obstacles! throughout! the! integration! process.!










criticisms,! some! researchers! have! started! to! investigate! if! the! expected! synergies!
actually!emerge,!or!if!those!synergies!are!rather!an!illusion.!They!are!claiming!that!M&As!
often!destroy!value!rather!than!create!it.!But!still,!it!is!interesting!to!see!the!large!number!
of! M&As! being! announced! by! companies! on! a! daily! basis.! It! becomes! even! more!








The! rationale! of! this! project! is! therefore! to! provide! a! comparative! analysis! for! the!
Pharmaceutical!and!Beauty–Personal!Care!sectors.!This!study!is!noteworthy!because!it!
focuses!on!value!creation!and!goodwill/synergy!descriptions!for!each!sector.!Finally,!the!












The! accomplishment! of! Real! Value! Creation! through! synergies! from! mergers! and!




























Pharmaceutical! and! Beauty–Personal! Care! sectors.! In! particular,! it! considers! the!
different!types!of!synergies!achieved!through!M&A!transactions.!Second,!its!objective!is!










The! objective! here! is! to! verify! whether! the! acquiring! companies! have! disclosed!
information! about! goodwill! properly,! especially! with! regard! to! its! nature! and! main!














The!substantial! research!materials!used! in! this! study!were! finance!books,! consulting!
companies’!and!institutions’!articles/reports,!articles!in!scientific! journals!related!to!the!
topic! of! mergers! and! acquisitions,! the! consolidated! annual/financial! reports! of! the!
acquiring!companies!from!both!sectors!including!the!2018!M&As!and!2016!IFRS!course!
slides.!All!of! these!resources!allowed!me!to!gather!all! the!necessary!secondary!data,!







the! sectoral! causes! for! applying! M&As! as! growth! strategy,! were! mainly! McKinsey’s!
article!(October!2018)!titled!“What’s)behind)the)pharmaceutical)sector’s)M&A)push”!and!
ATKearney’s! paper! titled! “Shop) or) Drop:) The) Inevitable) Path) for) Growth) in) Beauty”!
(2016).!McKinsey!and!ATKearney!are!American!worldwide!consulting!firms!conducting!
quantitative! and! qualitative! analyses! to! assess! management! decisions.! This! is! the!
reason!why! the! availability! of! their! documents!were! very! beneficial! to! attain! the! first!
research!objective.!The!first!part!of!the!second!objective,!the!description!of!goodwill,!was!
reached! using! 2018! Mergers! and! Acquisitions! in! Corporate! Finance! course! slides,!
especially! the! relating! session! to! “Value!Creation! and!Synergies! in!M&A”.! The! book!





Moreover,! the! remaining! aspects! of! the! second! objective! was! reached! by! collecting!





in!which! four! important! spreadsheets!were! created! in! order! to! attain! and!assess! the!





acquisitions! for! both! sectors! separately.! The! main! metrics! included! in! these! two!
spreadsheets,!graphs!and!tables,!are:!the!yearly!average!goodwill!and!purchase!price!
value! of! three! acquisitions,! the! goodwill! components,! the! ratio! of! goodwill! to!
consideration!paid,!and!the!growth!rate!for!each!of!these!values.!!
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"! The! CFO! margin! 2! years! after! acquisition:! calculation! is! 2! years! after!
acquisition!CFO!/!Net!sales!*!100!!
"! The! CFO! margin! 3! years! after! acquisition:! calculation! is! 3! years! after!
acquisition!CFO!/!Net!sales!*!100!!
"! The! CFO! margin! 4! years! after! acquisition:! calculation! is! 4! years! after!
acquisition!CFO!/!Net!sales!*!100!!
"! The! CFO! margin! 5! years! after! acquisition:! calculation! is! 5! years! after!
acquisition!CFO!/!Net!sales!*!100!!


















multiple! regression!analyses)!were!created! to! include! in!only!one!spreadsheet!all! the!
necessary!variables!needed!for!the!realisation!of!the!regression!analyses.!!
!


























































In! addition! to! this! introduction,! this! research! study! includes! a! literature! review! from!
academic!and!institutional!authors!aiming!to!provide!a!foundation!of!knowledge!on!the!
area!of!work!as!well!as!a!summary!and!a!synthesis!of!prior!research!findings.!In!other!









definition,! giving! explanations! on! the! variables! and! factors! considered! in! the! sample!
determination.!The!second!part!is!dedicated!to!the!sector!analysis!which!describes!the!









The! fourth!section! lists! the! limitations!of! this!study.!The! recognition!of!goodwill!as!an!
asset! and! its! subsequent! measurement,! such! as! the! impairment! test,! are! the! limits!
among!others!listed!in!this!part.!The!fifth!section!discusses!major!findings!and!suggests!
some!recommendations.!Finally,!the!conclusion!section!summarises!the!key!findings!of!
this! research.!A! further! research!section! is!also! included!because!various! interesting!
aspects! of! the!M&A!process!were!encountered!when! collecting!data.!This! document!









The! first! transaction! called! “Asset! Acquisitions”! or! “Assets! Deals”! exclude! certain!
liabilities! and/or! assets,! such! as! goodwill,! from! the! transaction! limit.! In! this! deal! the!
company!purchases!only!limited!assets!and!assumes!only!limited!liabilities!rather!than!a!






















the!empirical! research!are! included! in! this!data!study.!Each!of! the!parts!contribute! to!













business! combinations! from! various! perspectives.! The! following! literature! review! is!
classified!into!two!categories:!Academic!and!Institutional!authors.!!
2.1$ Literature$Review:$Academic$Authors$




allocations! and! the! determination! of! goodwill.! The! second! is! on! studies! that! analyse!
whether!goodwill!should!be!interpreted!as!an!asset.!The!third!area!of!work!regards!the!
subsequent! measurement! of! goodwill,! on! the! determinant! and! on! the! relevance! of!
impairment! tests! of! goodwill.! They! focus! mainly! on! research! commenced! since! the!
introduction!of!the!impairmentQonly!approach!of!SFAS!141!“Business'Combinations”!and!
SFAS! 142! “Goodwill' and' Other' Intangible' Assets”! by! the! U.S.! Financial! Accounting!
Standards!Board!(FASB)!in!2001!and!of!IFRS!3!“Business'Combinations”!and!IAS!36!
“Impairment'Assets”!by!the!International!Accounting!Standards!Board!(IASB)! in!2014.!






This! first! subQstudy! deals! specifically! with! the! purchase! price! allocations! and! the!
recognition! of! goodwill.! It! involves! descriptive! reports! on! American! and! European!
company!practices!in!regards!to!the!accounting!for!business!combinations.!Therefore,!it!











paid! is!allocated! to!goodwill,! in!spite!of!US!GAAP!and! IFRS’! rules!with! regard! to! the!
recognition!of!acquired!intangible!assets.!In!most!of!the!research!studies,!the!mean!ratio!
of!goodwill!to!price!paid!is!higher!than!fifty!percent!(see!Table#1).!Moreover,!the!study!
conducted! by! these! two! academic! authors! documents! that! the! ratio! of! goodwill! to!





acquirer!country!origin,!and! time!period!of!studies)!which!can! impact!and!explain! the!
result!from!one!study!to!another.!For!instance,!the!research!studies!realised!by!Ott!and!











The! second! subCstudy! deals! with! the! overCallocation! of! parts! of! the! consideration! to!
goodwill.! The! impairmentConly! approach! encourages!managers! to! allocate! significant!
proportions!of! the!cost!of! the!acquisitions!to!goodwill! rather! than!other!depreciable!or!
amortizable! assets.! In! fact,! providing! that! the! companies! stay! away! from! any!











subsample! “economic! profits”,! authors! find! a! positive! correlation! between! disclosed!
goodwill! and! the! economic! profit,! consistent! with! the! concept! that! these! business!
combinations!are!expected! to!achieve!synergies!over! time.!The!disclosed!goodwill! is!
























According! to! her! study,! the! goodwill! impairment! losses! are,! at! least! in! part,! the!
consequence! of! an! overpayment! for! the! target! entity! at! the! moment! of! acquisition.!
Moreover,!the!higher!the!amount!of!the!net!assets!acquired!with!the!acquiring!company’s!
shares,! the! higher! the! probability! of! occurrence! of! goodwill! impairment! losses! postU
acquisition.!Furthermore,!Olante’s!research!aligns!with!the!previous!researchers’!study!
results!with!regard!to!ratio!of!goodwill!to!consideration!paid!in!that!the!higher!the!ratio,!
the! higher! the! likelihood! of! having! subsequent! goodwill! impairment! losses.! Olante’s!
results!suggest!that!a!high!amount!of!goodwill!obtained!from!the!business!combination!
creates!a!higher!expectation!of!not!only!benefits!from!expected!synergies,!but!also!other!




Finally,! one! of! the! key! lessons! we! can! draw! from! Olante’s! research! paper! is! that!
companies!should!pay!significant!attention!to!the!assessment!of!the!target’s!book!value!
assets! in! order! not! to! overvalue! and! consequently! overpay! for! it.! Another! important!
lesson!is!that!managers!should!remain!skeptical!about!the!consideration!settlement!as!
it! is! proven! that! paying! in! stock! can! result! in! overpaid! acquisitions! and! subsequent!
goodwill!impairment!losses.!Moreover,!the!companies!should!not!wait!two!or!three!years!
after! the! acquisition! to! work,! but! rather! straight! afterward.! Otherwise,! the! business!










whether! distinct! intangibles! exist! in! some! business! combination! cases.! Furthermore,!
goodwill!reports!take!into!consideration!the!futureUoriented!and!companyUspecific!internal!
information,! which! are! subjective,! and! consequently! very! difficult! to! confirm.! The!
discretion!also!occurs!when!measuring! the!acquisitionUdate! fair! values!of! the! target’s!
assets!and!liabilities,!especially!from!intangible!assets,!such!as!technologies!or!IPR&D.!
In!order!to!assist!potential!investors!in!assessing!the!reliability!of!the!carrying!amount!of!
goodwill! estimated! by! management,! US! GAAP! and! IFRS! mandate! great! detailed!
disclosures! on! the! business! combinations! and! on! the! impairment! tests! of! goodwill.!
Despite! this! countervailing! measure,! academic! studies! reveal! that! companies’!
disclosures!do!not!actually!meet!US!GAAP!and!IFRS’!requirements.!!
2.2# Literature#Review:#Institutional#Authors#
In! addition! to! the! academic! authors,! there! are! some! institutional! authors,! mainly!





purchase!price! varies!according! to! the! industry.!EFRAG’s! study!about! “Goodwill! and!
Impairment”!reveals!that!the!ratio!differs!significantly!with!a!range!from!6.8%!to!71.6%!
(average! is!33.6%).!The! latter!adds! that! the!Telecommunication!Services,!Consumer!
Staples,!and!Industrials!industries!report!the!highest!ratios!while!Healthcare,!Consumer!




In!addition! to!Shalev!and!Glaum!et!al.! research!studies,! the!U.K.!Financial!Reporting!
Council! (FRC),! the!German!Financial!Reporting!Enforcement! (FREP),! as!well! as! the!
European!Securities!and!Markets!Authority!(ESMA)!are!three!other!institutional!bodies!




















In! addition! to! 2013! Report,! ESMA! reported! in! 2014! a! review! on! the! application! of!




3! requires!companies! to!disclose! information! that!allows!any!stakeholders!using! their!
financial! statements! to! assess! the! nature! and! financial! effect! of! the! business!










the!management! report!but!not! in! the!notes! to! the!consolidated! financial! statements.!





where!IFRS!3! leads!to!discrepancy! in!practice!or! lack!of!comparability,!and!where,! in!
consequence,!extra!clarification!or!guidance!would!be!needed!and!helpful!in!achieving!
the!key!objectives!of!the!financial!information!(see!Figure!4).!In!order!to!achieve!those!




Finally,! the! key! lesson! of! the! ESMA! 2014! Report! is! that! the! quality! of! the! financial!






























































The!samples!were! selected!by! first! identifying! two!sectors!where!many!mergers!and!














As! the! samples! include! large! stockPlisted! American! and! European! companies,! the!
















Over! the! past! 30! years,! the! Pharmaceutical! industry! has! become! progressively!
concentrated,! especially! these! last! 10! years.! In! other!words,!we! notice! a! substantial!
market! share! evolution! from! 2008! to! 2018! (see! Figure! 1! and! Figure! 2)! where! the!
industry! grew! to! be! under! the! dominance! of! 10! American! and! European! large!
companies.!The!main! reason!of! this!market! trend! is,!undoubtedly,! the! result!of!many!
M&As.!As!far!as!deal!value!is!concerned,!we!can!observe!during!the!1998P2000!period,!






































which!have!been!growing!considerably! these! last! years,!and!may!be! threatening! the!
large! American! and! European! companies! in! the! following! years.! In! addition,! it! is!






the! cost! of! new! technologies! is! increasing.! In! fact,! new! technological! equipment! is!
strongly!needed! in! research!and!development!activity!within! this! industry.! In!addition,!
some!new!policies!such!as!the!new!tax!reform!in!USA,!market!forces!such!as!blockbuster!
drugs!and!biotechnology!and!some!patent!expirations! (e.g.!Novartis),! that! result! in!a!













Studies! have! shown! that! the! portion! of! revenues! coming! from! innovations! realized!
outside!Big!Pharmaceutical!companies!has!considerably!grown!from!about!25%!in!2001!
to!about!50%!in!20167.!That!is!why!most!of!the!small!and!creative!Pharmaceuticals!as!
well! as!Biotechnical! companies,!mainly! startups,! have! been! purchased! by! the! larger!










as! the!combination!of! research!and!development!of! the!combined!companies’!allows!
substantial!cost!savings!due!to!the!overlapping!range!of!drugs!under!development.!In!
addition,! the! Biotechnical! companies! have! a! slight! better! EBITDA! margins! than!


























noteworthy! for! Big! Pharma! to! take! into! consideration! Ernst! and! Young’s! 2018!M&A!









The!Beauty–Personal!Care! industry! like! the!Pharmaceutical! industry!has!seen!a!high!
number!of!mergers!and!acquisitions!over!the!past!ten!years.!Throughout!these!years,!
the! key! industry! players! (see! Figure! 7! and! Figure! 8)! developed! their! business! by!








45%!market! share! on! a! combined! basis.! Therefore,! the! large! companies! have! been!



































































within! the! Beauty–Personal! Care! sector.! In! fact,! local! companies! enable! large!
corporations!rapid!access!to!local!distribution!channels,!but!this!does!not!only!regard!the!
time!and!capital!needed!to!be!saved!but!also!the!import!barriers!to!avoid.!Furthermore,!




A! good! example! of! this! is! L’Oréal! again.! The! large! French! cosmetic! company! has!


















There! is! a! need! for! companies! in! the! retail! sector! to! strengthen! or! build! their! sales!
infrastructure!as!their!core!objective!is!to!maximize!sales!of!products,!not!only!in!their!
home!countries!but!all!over!the!world.!That!is!why!BPC!companies!are!not!only!acquiring!
companies! to! complete! their! product! portfolios! but! also! distribution! channels! to!
commercialize!them!faster!on!targeted!markets.!!
!
An! example! of! this! is! the!American! cosmetic! company,!Coty.! It! has! purchased!U.K.!
distribution!business!Lena!White!in!2013!in!order!to!strengthen!control!of!its!brand!in!the!
U.K.!market!which! then!would! result! in! the! fast! commercialization! through! retail! and!
professional!channels.!According!to!some!studies,!Lena!White!became!Coty’s! largest!
distribution!channel! for!of! its! leading!colour!cosmetic!brand!OPI.!We!can!observe!an!
increase! postPacquisition! of! the! Cash! Flow! from! Operations! margin! from! 9.98%! to!
11.53%,!3!years!following!the!purchase.!!
!




It! is! fundamental! for! companies! in! the!FMCG! industry,! especially! for!BPC! to! have!a!
closer!look!into!innovation!due!to!a!shortening!product!life!cycle.!The!market!players!in!




















there!are! five!principal! trends!more!specifically!driving!M&As! in! the!Beauty–Personal!
Care!sector!in!201711.!In!this!sector,!M&As!activity!has!continued!in!2017!at!record!levels,!










3.! Retailers!differentiating! their!offer! through!owned!brands:! for! instance,!because!
retailers!can!offer!premium!shelf!as!they!own!the!brands.!
4.! High!growth!in! ‘indie’!brands!attracting!large!corporate!buyers:!smaller! inspiring,!
innovative!and!independent!brands!have!started!to!disrupt!the!cosmetic!industry.!
















11! WISEMAN,! Matthew,! 2017.! Personal! care! and! beauty:! top! 5! trends! driving! M&A! in! 2017.!













Despite! how! important! the! supply! chain! is,! Pharmaceutical! companies! committed!
relatively! low! efforts! to! the! reconfiguration! of! their! manufacturing! and! distribution!
operations! these! last!years.!However,!according! to!some!analysts,!by! the!year!2020,!




As! in! the!Pharmaceutical! sector,! the!Beauty–Personal!Care!companies!see!changes!
within! the! sector! such! as! innovative! customer! demands! and! personalised! product!
offerings.! This! therefore! results! in! changes! in! business! operations! such! as! in! the!








to! the! technological! evolvement.! The! second! common! cause! is! “Increasing!
manufacturing!capabilities”!as!these!new!technologies!are!very!costly,!M&A!deals!are!a!
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!





14! FENECH,! Céline,! PERKINS,! Ben,! 2015.! MadePtoPorder:! The! rise! of! mass! personalization.!












The! Beauty–Personal! Care! industry! is! more! performance! driven.! According! to!







As! there!are!several!phases,! three! in!general,! in! the!development!of!a!new!drug,! the!
acquirer!cannot!completely!capitalize!straight!after! the!acquisition.!Also,! for!each!new!
drug!proposal,!companies!must!receive!the!New!Drug!Approval!(NDA)!from!regulatory!





and! customer’s! needs,! there! are! some! similarities! in! terms! of! strategic! decisions! on!
M&As!strategy.!It!is!true!that!the!new!technologies!impact!these!sectors!in!a!significant!










15!WEINTRAUB,!Arlene,! 2019.!Novartis!CEO! figures!M&A's! the!way! toward! 'transformative'! innovation:!









On! the! other! side,! Procter! and!Gamble!with! P&G!Ventures! started! to! generate! new!
innovative! product! ideas! and! offerings! (about! 40)! in! various! stages! of! development!






















The! third! part! of! the! data! analysis! regards! the! selected! sectors! and! its! companies’!
behaviours! and! performance! (from! 2003! to! 2018)! without! taking! into! consideration!








that! Pharmaceutical! companies! establish!many!M&As! as! the! Beauty–Personal! Care!
companies.!For!example,!Novartis!and!Roche!in!the!Pharmaceutical!sector!and!L’Oréal!




instead! of! creating! value! with! their! acquired! businesses! (the! soPcalled! “hubris!
syndrome”).!
3.3.1! Pharmaceutical!sector!
The! company’s! CFO!margin! in! the! Pharmaceutical! sector! is! not! constant! over! time,!
meaning!that!each!acquisition!does!not!impact!the!company’s!performance!in!the!same!
way.!As!Figure! 9! (below)! shows,! the! yearly! average! of!CFO!margin! of! all! acquiring!
companies!combined! is!more!or! less!constant! from!2003!to!2018!with!a!range!from!M














































Company’!CFO!margin! in! the!Beauty–Personal!Care!sector! is!also!not!constant!over!
time.!Business! combinations!are! not! all! recognized! in! the! same!way,! as! each!brand!
bought! has! different! characteristics! such! as! product! segment,! country! of! origin! and!































2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018












The!main! similarity! between! these! two! sectors! is! that! from! 2003! to! 2018! the! yearly!







Table! 5).! This! means! that! companies! did! not! continuously! achieve! synergies! as!
expected! in! this!sector.!There! is! indeed!always!this!“unknown!on!the!game”!meaning!
that! firms!do!not!know!at!all!whether!the!R&D!on!new!drugs!will!be!profitable.!As!the!
latter! represents! their! core! activity,! the! new! medicines’! failure! impact! them! heavily.!
Moreover,! Pharmaceutical! companies! due! to! the! patents! expiration,! also! lose! their!
competitiveness!as!there!are!more!and!more!generic!products!for!cheaper!prices!on!the!
market.!However,!it!is!noticeable!that!the!CFO!margin!generated!by!Big!Pharmaceuticals!
is! much! higher! than! the! BeautyPPersonal! Care.! This! proves! in! a! way! the! business!
statement!“the'higher'the'risk,'the'higher'the'return”.!As!companies!in!this!industry!are!
























challenging! issues! in! financial! reporting.! It! is! also! found! in! this! study,! such!as! in! the!
previous!literature!review,!that!many!companies!still!do!not!properly!disclose!information!












This! research! study! identifies! three! characteristics! of! value! creation! arising! from! an!
acquisition!which!can!be!listed!as!follows:!!
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-! “The' closing' of' duplicative' facilities' and' other' site' rationalization' actions'





















































loss! of! focus! during! the! transaction! process.! The! following! negative! synergies20! are!
examples!among!others:!
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The! number! of! “Not! mentioned”! goodwill! components! in! the! Beauty–Personal! Care!





















































Efficiency!–! The! third! and! last! characteristic! concerns! all! the! “Others”! components!
which! are! not! synergies! or! assembled! workforce.! It! has! been! found! that! the!
Pharmaceutical! sector,! as! it! is!more! transparent,! disclosed! “Others”! component! (see!
Figure!14)!in!almost!all!completed!acquisitions!achieved!in!the!2008P2017!period.!The!
most!significant!one!is!the!“Future!and!New!products!and!projects”!being!in!line!with!level!
5!synergies!of! the!synergy!map.!This!may!raise!concerns!about!the! low!probability! to!
achieve! those! synergies.! This! proves! the! earlier! McKinsey! statement! about! the! key!
fundamental!drivers!being! thus!“M&As!to!realign!Portfolios”.! In!contrast,! the!Beauty!–!
Personal!Care!sector!disclose!“Others”! in!very! few!business!combinations!and!where!
the!only!explanations!are!either!tax!purposes!or!future!marketP!segment!expansion.!Also,!




One!of! the!most! illustrative!examples!of! synergies!achievement! in! the!BPC!sector! is!
Henkel’s!acquisition!of!Procter!and!Gamble!(“P&G”)!hair!care!brands!in!2016!–!it!is!stated!
that!goodwill!was!recognized!for!tax!purposes!for!this!specific!P&G!acquisition21!,!and!











































has!been!discovered,!Pharmaceutical! companies!are! fighting!each!other! to!buy! it.! In!
addition,!each!peak!is!in!the!range!of!40%!and!55%!more!or!less!and!the!rate!for!each!
bottom!is!in!the!range!of!30%!and!40%,!except!2006!where!the!rate!is!even!below!30%.!














particular,! for! instance!L’Oréal.! It! is!noticed! from! its!2009!Financial!Report,! there! is!a!
significant! decrease! in! the! money! spent! for! business! combinations! in! 2008! (€1150!
million)!and!2009!(€650!million23).!This!is!probably!due!to!the!2008!financial!crisis!which!
impacted!the!company’s!operations.!In!regards!to!the!2012!peak,!there!is!less!money!




of! PPA! is! more! or! less! constant! meaning! there! are! not! a! lot! of! peaks! like! in! the!

























Figure! 17! illustrates! the! CFO! margin! at! acquisition! when! compared! to! the! 5Pyear!












period!of! time.!Like! in! the!Pharmaceutical!sector,! firms! in! this!sector!do!not!generate!
























and' liabilities' is' recorded' as' Goodwill' and' allocated' to' the' Cash' Generating' Units'
expected'to'benefit'from'the'acquisition'or'the'related'synergies.24”'
!
One! of! the! most! illustrative! examples! of! goodwill! component! disclosure! in! the!
Pharmaceutical! sector! is! Novartis’! acquisition! of! Genoptix! Inc.! –! it! stated! “Goodwill'
arising' out' of' the' acquisitions' reflects'mainly' the' value' of' expected' synergies,' future'
products'and'the'acquired'assembled'workforce.25”'
!
In! addition,! the! Pharmaceutical! sector! tries! to! be!more! transparent! than! BPC! in! the!
goodwill! component! disclosure!as!most! of! the!Pharma!companies!give! the!nature!of!
goodwill.!They!even! include! the!detailed!description!of! the!“Others”!component.!Also,!
few!of! the!BPC!firms!explain!how!and!where!expected!synergies!will!be!achieved.! In!
compliance! with! IFRS! accounting! best! practice,! it! is! mandatory! for! the! acquiring!
companies! to! provide! more! extended! as! well! as! more! uniform! information! and!


















on! the! sample! of! this! study,! BPC! firms! in! contrast! to! the! Pharmaceuticals! do! not!
recognize!greater!amount!of!goodwill!as!assembled!workforce,!only!13.6%!whereas!the!
rate!is!double!in!the!Pharma!(26.7%).!Expected!synergies!(52.3%)!are!seen!as!the!main!





Furthermore,! despite! a! lower! value! of! purchase! price! and! goodwill! compared! to! the!
Pharmaceutical! industry,! companies! in! the!Beauty!–!Personal!Care! sector! allocate!a!
higher!amount!of! the!purchase!price! to!goodwill! (see!Appendix!17)!and!not! to!other!
assets! such! as! CustomerPrelated! intangibles! (e.g.! customer! relationship),!MarketingP
















The! fifth!and! last!part! of! the!data!analysis! consists! in!a! simple! (first! hypothesis)!and!
multiple! (second! hypothesis)! regression! analyses.! The! objective! is! to! understand!























Figure! 19! (below)! illustrates! the! scatter! plot! which! plots! Y! against! β1X1! and! the!








































is! indeed! substantially! higher! than! the! tPvalue! (19.62! >! 2.0211P2.0086)! which! could!






















Figure! 20! (below)! illustrates! the! scatter! plot! which! plots! Y! against! β1X1! and! the!







































value! being! between!2.0211! and!2.0086! (see!Appendix! 10).!Moreover,! the! tPstat! is!
indeed!significantly!higher!than!the!tPvalue!(17.71!>!2.0211P2.0086)!which!could!indicate!



























that! being! There' is' no' relationship' between' additional' operating' cash' flows' post'




As! it! is! shown! in! the! below! equation,! the! dependant! variable! Y! represents! the!
added_CFO!and!the!independent!variables!β1X1!represents!the!goodwill!divided!by!4,!












H0:! there! is! no! relationship! between! additional! operating! cash! flows! post! acquisition!
(“added_CFO”)!and!a!theoretical!4Pyear!amortization!of!acquired!goodwill!(“GW/4”)!



























H0:! there! is! no! relationship! between! additional! operating! cash! flows! post! acquisition!
(“added_CFO”)!and!a!theoretical!4Pyear!amortization!of!acquired!goodwill!(“GW/4”)!!





















The!main!similarities!between!both!sectors! is! that! the!Null!Hypothesis! is!not! rejected!
meaning!there!is!a!no!relationship!between!the!added_CFO!and!the!value!of!goodwill!
divided! by! 4! years.! Even! the! others/4! and! Location! do! not! explain! any! relationship.!






the! consideration! paid,! triggering! a! high! amount! of! acquired! goodwill,! the! higher! are!
expected!future!CFO.!!!
!
One!assumption!explaining! the!additional!CFO!can!be! that! they!are! from!other!postP
















The! target’s!company!valuation! (tools!and!methodologies),! the!other!parts!of! the!due!
diligence! (e.g.! risk! management),! and! the! business! combinations! resulting! into! a!
negative!goodwill!are!three!other!aspects!beyond!this!study.!!
!
In! regards! to! goodwill,! this! research! study! does! not! address! the! topics! on! the!
measurement!of!goodwill,! the!goodwill! interpretation!(e.g.!whether!goodwill!should!be!




















Based! on! this! study,! Pharmaceutical! and! Beauty–Personal! Care! industries! share!
similarities,!starting!with!the!causes!for!using!M&As!as!a!growth!strategy.!The!opportunity!
to! increase! product! range,!manufacturing! capabilities,! and! distribution! range! are! the!
major!common!reasons!for!these!companies!to!expand!their!business!through!M&As.!
Also,! the! technological! evolvement! has! become! the! primary! need! for! corporations!
operating!in!these!two!sectors.!Therefore,!in!order!to!succeed!in!this!highly!competitive!
business!world,! they!have! to! take! this! into! consideration!while!deciding!on! their!new!
business!combinations.!!
!
Additionally,! another! significant! outcome!of! the!data!analysis! relates! to! the!nature!of!
goodwill.! The! description! of! this! key! intangible! asset! is! not! properly! disclosed! in! the!
companies’!consolidated!financial!statements,!especially!for!the!BPC!sector!in!the!2003P
2008! period.! This! confirms! the! outcome! of! prior! studies,! primarily! from! institutional!
authors! such! as! ESMA.! We! emphasize! the! Pharmaceutical! sector! as! being! more!
transparent,! in! contrast! to! the! BPC! sector.! Moreover,! disclosing! whether! goodwill!
represents!expected!synergies!and/or!assembled!workforce,!entities!in!this!industry!do!
reveal! the!“other”!components.!Almost! in!each!acquisition,!Pharmaceutical! firms!have!




results! with! regard! to! goodwill! value! demonstrate! a! strong! correlation! between! the!
amount! of! goodwill! and! the! consideration!paid.!Nevertheless,! the!multiple! regression!




















We! can! highlight! another! finding! on! goodwill.! In!most! of! the! business! combinations,!
management!have!not!communicated!how!and!where!they!have!achieved!the!expected!






























M&As! are! perceived! either! as! value! enhancing! or! destructing! for! corporations.!






In! fact,! these! two! sectors! have! different! reasons! and! drivers! for! applying! growth!
strategies! through! M&As.! For! Pharmaceutical! firms,! M&As! is! perceived! primarily! as!
sources! of! “Innovation”,! “Synergies,! and! “Portfolios”,!whereas! in! the!BPC!sector! it! is!
mainly! observed! as! sources! of! access! to! new! “Consumers”,! new! “Markets”,! new!





In! addition! to! these! three! common! causes,! it! is! noticeable! that! innovation! became!
another! common! key! argument! for! firms! in! their! decisions! for! merging! or! acquiring!
businesses.!In!order!words,!nothing!is!set!in!stone!and!customers’!needs!are!changing,!
new! equipment! is! needed! in! the! supply! chain,! and! new! technologies! and! electronic!
devices! require!new!knowledge!and!new!capabilities.!The!cost! associated!with!all! of!
these! changes! is! increasing! over! time.! That! is! why,! in! order! to! grow! profitably! and!





Care!sectors,! the!synergies!achieved!are! “Real!Value!Creation”! rather! than!“Illusion”.!








two! other! key! points! which! need! to! be! emphasized.! The! first! key! point! is! that! the!
difference!between!the!CFO!margin!at!acquisition!and!the!5Pyear!average!CFO!margin!
for!each!business!combination!is!very!little.!The!second!is!that!even!though!there!is!a!








































models! and! strategies.! In! order! to! maximise! the! probability! of! longPterm! success! of!
M&As,! corporations! must! take! into! consideration! three! fundamental! aspects! in! their!
business!growth!strategy.!The!first!is!the!environmental!dimension,!driving!customers!
to!new!needs!and!priorities.!We!can!see!more!and!more!ecoPfriendly/bio!products!on!the!
market! as! well! as! “sustainable! innovation”! or! “sustainable! future”! statements! from!
companies! in! the! FMCG! and! BPC! sectors.! The! second! is! the! technological!
evolvement,!and!the!third!one!is!the!Big!Data!Analytics,!which!are!substantially!driving!
Pharmaceuticals’!future.!The!ability!to!find!a!way!using!these!extremely!large!data!sets!
might! allow! Pharmaceutical! companies! to! conduct! clinical! trials! without! the! need! of!
patients!by!modelling!key!traits26.! It!could!also!enable!consumers! to! identify!and!cure!
diseases!themselves!at!home!on!a!predictive!or!preventive!basis.!!
!
Roche’s! acquisition! of! Flatiron! Health! (U.K.)! with! a! purchase! price! of! CHF1,553.00!
million27! and! a! goodwill! of! CHF1,128.00! million,! which! represents! 72.63%! ratio! of!
goodwill! to! purchase! price! leads! to! an! interesting! area! of! work! which! needs! to! be!
considered.!This!amount!of!goodwill!has!been! the!highest! for! this!sector!since!2003.!
According! to! Roche’s! financial! report,! “Goodwill' represents' value' of' accelerating'
progress'towards'data@driven'personalised'healthcare'in'cancer'and'to'advance'the'use'










26! JUNAIDEEN,! Amry,! 2019.! In! the! future! of! health,! risk! is! inevitable…and! we! should! harness! it.!
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